Comparing a wearable optical blood pressure band with a traditional upper‑arm cuff for people with high blood pressure
Official title: WEARABLE-BP: Wearable Everyday Automated Readings to Enable Assessment of Blood Pressure Control
Run by Aktiia SA · NCT07523269 · Data updated 2026-11-12
This study will test whether using the Aktiia G1 wearable blood pressure monitor helps people with high blood pressure control their blood pressure better than a traditional upper‑arm cuff.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 21 Years to 85 Years |
| Sex | All |
| Enrollment | 164 (estimated) |
| Sponsor | Aktiia SA Industry-sponsored |
| Locations | 1 site (Boston, Massachusetts) |
| Status | Recruiting |
| Started | April 2026 |
| Main results expected | September 2027 |
| Study ends | December 2027 |
| Registry record updated | April 13, 2026 |
| Trial ID | NCT07523269 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 21–85 years old with uncontrolled systolic hypertension (>135 mmHg by unattended automated office measurement), on 0–2 antihypertensive medications, who own a smartphone, can read English, have an MGB provider/EPIC record, and can attend two on‑site visits are ideal candidates.
✕Probably not a fit
People with severe hypertension (SBP >180 mmHg or DBP >120 mmHg), severe heart failure, advanced CKD, pregnancy, very high resting heart rate, or those without a smartphone or access to the Mass General Brigham system are unlikely to benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective, open‑label, two‑arm randomized trial enrolling about 164 adults with uncontrolled hypertension. Participants are randomly assigned to wear an Aktiia G1 optical wrist monitor for 12 months or to use a validated upper‑arm cuff for the first 6 months and then switch to the Aktiia device for the final 6 months. The primary comparison is change in unattended automated office systolic blood pressure from baseline to 6 months, with additional data collected from device measurements and online lifestyle and health surveys. The trial is sponsored by Aktiia SA in collaboration with Mass General Brigham and conducted at Mass General Brigham sites in Boston.
Why it matters
Potential benefit: If successful, continuous wearable BP monitoring could make it easier to detect and manage uncontrolled blood pressure and improve overall BP control outside the clinic.
How similar studies have gone: Previous observational and short‑term studies of cuffless and wearable BP technologies have produced mixed results, and randomized comparisons of continuous optical monitors versus standard cuffs remain limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults aged 21 to 85 years. * Able to read and speak English. * Have an MGB provider and medical record number in EPIC * Study participants will wear the Aktiia bracelet for 6 months * Willing to attend two on-site study visits and comply with all study procedures. * Signed informed consent provided. * Own a smartphone with iOS or Android operating system. * Hypertensive with uncontrolled systolic blood pressure (SBP) \>135 mm Hg by unattended automated office measurement * Currently taking 0, 1 or 2 antihypertensive medications. Exclusion Criteria: * Severe hypertension (SBP \> 180 mmHg or DBP \> 120 mmHg). * Pregnant or breastfeeding. * Known severe heart failure (LVEF \< 35%). * Known severe valvular heart disease. * Known pheochromocytoma. * Known severe chronic kidney disease (CKD stage 4-5; eGFR \< 30 mL/min/1.73 m²). * Known uncontrolled hyperthyroidism or hypothyroidism. * Known severe diabetes (Hemoglobin A1c \> 10%). * Known resting heart rate \> 120 bpm. * Known persistent atrial fibrillation. * Known Raynaud's disease. * Known tremors or shivering disorders. * Known exfoliative skin diseases. * Known allergy to silicone. * Presence of lymphedema. * Paralysis of the arm. * Arm amputation. * Presence of implanted devices, such as a pacemaker, defibrillator, intravascular device, or arteriovenous fistula. * Upper arm circumference \< 22 cm or \> 42 cm. * Wrist circumference \> 23 cm. * Mastectomy
Where it's running
-
Mass General Brigham Hospital
Boston, Massachusetts, United States Recruiting
Study contacts
- Study coordinator: Kristen Harriott
- Email: BWHWearableBP@mgb.org
- Phone: 617-525-8493
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Guiding Optimal Blood Pressure in Peritoneal Dialysis
This pilot tests whether aiming for a lower systolic blood pressure target (<120 mmHg) is feasible and practical for adults with end-stage kidney disease on peritoneal dialysis, compared to a <140 mmHg target.
-
New virtual care pathway for older adults with chronic diseases
A teleconsultation-based care pathway for adults 60+ with hypertension, diabetes, or dyslipidemia to see if it’s feasible and cost-saving in Malaysian primary care compared with usual clinic visits.
-
Isometric Handgrip Exercise to Lower Blood Pressure in Pregnant Women
This study tests whether doing isometric handgrip exercises can help lower blood pressure in pregnant women, including those with chronic hypertension.
-
Investigating microcirculation with non-invasive devices in adults with or at risk for CKD
This study tests two non-invasive devices (HEMI and SPG-NINOX) to see how small blood vessels behave in adults with or at risk for chronic kidney disease, hypertension, or type 2 diabetes.
-
Mobile home BP monitoring with coaching after high blood pressure from pregnancy
This program tests whether a home blood pressure monitoring system plus virtual coaching can help midlife women, 10–20 years after a hypertensive pregnancy, manage high blood pressure better than usual care.
-
Low energy availability and high blood pressure in Division I HBCU athletes
This project will test whether not eating enough for heavy training (low energy availability) is linked to higher blood pressure and stiffer arteries in Division I HBCU athletes ages 18–25.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.